{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:40:22Z","timestamp":1759682422858,"version":"build-2065373602"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["RSP2023R235"],"award-info":[{"award-number":["RSP2023R235"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.neuroscience.2023.11.014","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T11:51:28Z","timestamp":1701172288000},"page":"58-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effects of Beta Lactams on Behavioral Outcomes of Substance Use Disorders: A Meta-Analysis of Preclinical Studies"],"prefix":"10.1016","volume":"537","author":[{"given":"Mohammed S.","family":"Alasmari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar A.","family":"Almohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3800-1220","authenticated-orcid":false,"given":"Alaa M.","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid A.","family":"Altulayhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bader K.","family":"Alkadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah F.","family":"Alasmari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faleh","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youssef","family":"Sari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2382-5892","authenticated-orcid":false,"given":"Fawaz","family":"Alasmari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2023.11.014_b0005","unstructured":"Abramson, A., 2021. Substance use during the pandemic. American Psychological Association 52, 22. Available at: https:\/\/www.apa.org\/monitor\/2021\/03\/substance-use-pandemic."},{"key":"10.1016\/j.neuroscience.2023.11.014_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.841036","article-title":"Ceftriaxone as a novel therapeutic agent for hyperglutamatergic states: Bridging the gap between preclinical results and clinical translation","volume":"16","author":"Abulseoud","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0015","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/npp.2014.14","article-title":"Attenuation of ethanol withdrawal by ceftriaxone-induced upregulation of glutamate transporter EAAT2","volume":"39","author":"Abulseoud","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2012.03.045","article-title":"Ceftriaxone upregulates the glutamate transporter in medial prefrontal cortex and blocks reinstatement of methamphetamine seeking in a condition place preference paradigm","volume":"1456","author":"Abulseoud","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00213-013-3047-3","article-title":"Effects of the beta-lactam antibiotic ceftriaxone on nicotine withdrawal and nicotine-induced reinstatement of preference in mice","volume":"228","author":"Alajaji","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neulet.2015.06.015","article-title":"Effects of ampicillin on cystine\/glutamate antiporter and glutamate transporter 1 isoforms as well as ethanol drinking in male P rats","volume":"600","author":"Alasmari","year":"2015","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0035","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3390\/biom10071030","article-title":"Ampicillin\/sulbactam treatment modulates NMDA receptor NR2B subunit and attenuates neuroinflammation and alcohol intake in male high alcohol drinking rats","volume":"10","author":"Alasmari","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2015.11.010","article-title":"Targeting glutamate homeostasis for potential treatment of nicotine dependence","volume":"121","author":"Alasmari","year":"2016","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.brainres.2016.01.007","article-title":"Effects of cefazolin and cefoperazone on glutamate transporter 1 isoforms and cystine\/glutamate exchanger as well as alcohol drinking behavior in male alcohol-preferring rats","volume":"1634","author":"Alasmari","year":"2016","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0050","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.brainresbull.2020.10.012","article-title":"Effects of chronic ethanol consumption on the expression of GLT-1 and neuroplasticity-related proteins in the nucleus accumbens of alcohol-preferring rats","volume":"165","author":"Alhaddad","year":"2020","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0055","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1007\/s00213-014-3545-y","article-title":"Effects of ceftriaxone on ethanol intake: a possible role for xCT and GLT-1 isoforms modulation of glutamate levels in P rats","volume":"231","author":"Alhaddad","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1124\/jpet.122.001147","article-title":"Effects of a novel beta lactam compound, MC-100093, on the expression of glutamate transporters\/receptors and ethanol drinking behavior of alcohol-preferring rats","volume":"383","author":"Alhaddad","year":"2022","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0065","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.bbr.2018.03.043","article-title":"Effects of ceftriaxone on hydrocodone seeking behavior and glial glutamate transporters in P rats","volume":"347","author":"Alshehri","year":"2018","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12031-018-1194-z","article-title":"Effects of clavulanic acid treatment on reinstatement to methamphetamine, glial glutamate transporters, and mGluR 2\/3 expression in P rats exposed to ethanol","volume":"67","author":"Althobaiti","year":"2019","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0075","doi-asserted-by":"crossref","first-page":"11349","DOI":"10.4088\/JCP.20f13681","article-title":"Mean difference, standardized mean difference (SMD), and their use in meta-analysis: as simple as it gets","volume":"81","author":"Andrade","year":"2020","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0080","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1111\/bph.13330","article-title":"Ceftriaxone attenuates acute cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens of the rat","volume":"172","author":"Barr","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0085","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00213-017-4802-7","article-title":"The effects of ceftriaxone on cue-primed reinstatement of cocaine-seeking in male and female rats: estrous cycle effects on behavior and protein expression in the nucleus accumbens","volume":"235","author":"Bechard","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1037\/bne0000297","article-title":"The effects of clavulanic acid and amoxicillin on cue-primed reinstatement of cocaine seeking","volume":"133","author":"Bechard","year":"2019","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0095","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.drugalcdep.2019.01.005","article-title":"The effects of Pavlovian cue extinction and ceftriaxone on cocaine relapse after abstinence","volume":"197","author":"Bechard","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0100","doi-asserted-by":"crossref","first-page":"e12928","DOI":"10.1111\/adb.12928","article-title":"Role of prefrontal cortex projections to the nucleus accumbens core in mediating the effects of ceftriaxone on cue-induced cocaine seeking","volume":"26","author":"Bechard","year":"2021","journal-title":"Addict Biol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0105","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.23963","article-title":"Sex differences, gender and addiction","volume":"95","author":"Becker","year":"2017","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0110","series-title":"Drug Abuse and Addiction in Medical Illness","first-page":"73","article-title":"Animal models in addiction research","author":"Belin","year":"2012"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0115","doi-asserted-by":"crossref","first-page":"e049924","DOI":"10.1136\/bmjopen-2021-049924","article-title":"Social and structural determinants of injecting-related bacterial and fungal infections among people who inject drugs: protocol for a mixed studies systematic review","volume":"11","author":"Brothers","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0120","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025247","article-title":"\u03b2-lactams and \u03b2-lactamase inhibitors: An overview","volume":"6","author":"Bush","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2011.12.029","article-title":"The beta-lactam antibiotic, ceftriaxone, inhibits the development of opioid-induced hyperalgesia in mice","volume":"509","author":"Chen","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0130","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/acsmedchemlett.0c00006","article-title":"The resurrection of phenotypic drug discovery","volume":"11","author":"Childers","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0135","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-013-8598-0","article-title":"Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson\u2019s model","volume":"49","author":"Chotibut","year":"2014","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(14)70222-4","article-title":"Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: A multi-stage, randomised, double-blind, placebo-controlled trial","volume":"13","author":"Cudkowicz","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0145","doi-asserted-by":"crossref","first-page":"e13178","DOI":"10.1111\/adb.13178","article-title":"Role of suppressing GLT-1 and xCT in ceftriaxone-induced attenuation of relapse-like alcohol drinking in alcohol-preferring rats","volume":"27","author":"Das","year":"2022","journal-title":"Addict Biol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuropharm.2015.05.009","article-title":"Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats","volume":"97","author":"Das","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ebm2.7","article-title":"A protocol format for the preparation, registration and publication of systematic reviews of animal intervention studies","volume":"2","author":"De Vries","year":"2015","journal-title":"Evid Based Preclin Med"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0160","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","article-title":"The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"5","author":"Degenhardt","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0165","doi-asserted-by":"crossref","first-page":"9319","DOI":"10.1523\/JNEUROSCI.3278-12.2013","article-title":"Role of the major glutamate transporter GLT1 in nucleus accumbens core versus shell in cue-induced cocaine-seeking behavior","volume":"33","author":"Fischer","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/10550887.2021.1926889","article-title":"The effect of prescribing antibiotics with opioids on the development of opioid use disorder: A national database study","volume":"40","author":"Freedman","year":"2022","journal-title":"J Addict Dis"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0175","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.physbeh.2015.06.009","article-title":"Ceftriaxone attenuates acquisition and facilitates extinction of cocaine-induced suppression of saccharin intake in C57BL\/6J mice","volume":"149","author":"Freet","year":"2015","journal-title":"Physiol Behav"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0180","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/mp.2015.151","article-title":"Glutamatergic mechanisms of comorbidity between acute stress and cocaine self-administration","volume":"21","author":"Garcia-Keller","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-021-02072-8","article-title":"Interactions of neuroimmune signaling and glutamate plasticity in addiction","volume":"18","author":"Gipson","year":"2021","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0190","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.brainres.2015.07.008","article-title":"Amoxicillin and amoxicillin\/clavulanate reduce ethanol intake and increase GLT-1 expression as well as AKT phosphorylation in mesocorticolimbic regions","volume":"1622","author":"Goodwani","year":"2015","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2017.02.024","article-title":"Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder","volume":"77","author":"Goodwani","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0200","doi-asserted-by":"crossref","DOI":"10.1186\/s13031-021-00407-z","article-title":"Priorities for addressing substance use disorder in humanitarian settings","volume":"15","author":"Greene","year":"2021","journal-title":"Confl Health"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0205","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuropharm.2016.04.014","article-title":"Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator","volume":"108","author":"Gregg","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.alcohol.2021.01.004","article-title":"Effects of ceftriaxone on ethanol drinking and GLT-1 expression in ethanol dependence and relapse drinking","volume":"92","author":"Griffin","year":"2021","journal-title":"Alcohol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0215","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pbb.2011.04.012","article-title":"Role of GLT-1 transporter activation in prevention of cannabinoid tolerance by the beta-lactam antibiotic, ceftriaxone, in mice","volume":"99","author":"Gunduz","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0220","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.aat.2014.11.001","article-title":"Attenuation of morphine-induced dependence and tolerance by ceftriaxone and amitriptyline in mice","volume":"52","author":"Habibi-Asl","year":"2014","journal-title":"Acta Anaesthesiol Taiwan"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0225","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40473-022-00252-1","article-title":"Glutamatergic Agents for the Treatment of Cocaine Use Disorder","volume":"9","author":"Hadizadeh","year":"2022","journal-title":"Curr Behav Neurosci Rep"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0230","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bbr.2016.12.016","article-title":"Effects of orally administered Augmentin on glutamate transporter 1, cystine-glutamate exchanger expression and ethanol intake in alcohol-preferring rats","volume":"320","author":"Hakami","year":"2017","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0235","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.bbr.2018.09.015","article-title":"\u03b2-lactams modulate astroglial glutamate transporters and attenuate dependence to CP 55,940, a CB1 receptor agonist, in rat model","volume":"359","author":"Hakami","year":"2019","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0240","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neulet.2017.08.013","article-title":"\u03b2-Lactamase inhibitor, clavulanic acid, attenuates ethanol intake and increases glial glutamate transporters expression in alcohol preferring rats","volume":"657","author":"Hakami","year":"2017","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0245","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbr.2017.06.017","article-title":"Modulatory effects of Ampicillin\/Sulbactam on glial glutamate transporters and metabotropic glutamate receptor 1 as well as reinstatement to cocaine-seeking behavior","volume":"332","author":"Hammad","year":"2017","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0250","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/alcalc\/agaa104","article-title":"Effect of modulation of the astrocytic glutamate transporters\u2019 expression on cocaine-induced reinstatement in male p rats exposed to ethanol","volume":"56","author":"Hammad","year":"2021","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0255","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainresbull.2022.04.014","article-title":"Effects of waterpipe tobacco smoke and ceftriaxone treatment on the expression of endocannabinoid receptors in mesocorticolimbic brain regions","volume":"185","author":"Hammad","year":"2022","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0260","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/alcalc\/agaa010","article-title":"Effects of cocaine exposure on astrocytic glutamate transporters and relapse-like ethanol-drinking behavior in male alcohol-preferring rats","volume":"55","author":"Hammad","year":"2020","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0265","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neuroscience.2021.03.030","article-title":"Ceftriaxone reduces waterpipe tobacco smoke withdrawal-induced anxiety in rats via modulating the expression of TNF-\u03b1\/NF\u0138B, Nrf2, and GLT-1","volume":"463","author":"Hammad","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0270","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1073\/pnas.1519248113","article-title":"Reversal of morphine-induced cell-type\u2013specific synaptic plasticity in the nucleus accumbens shell blocks reinstatement","volume":"113","author":"Hearing","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0275","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ilar\/ilu042","article-title":"Meta-analyses of animal studies: an introduction of a valuable instrument to further improve healthcare","volume":"55","author":"Hooijmans","year":"2014","journal-title":"ILAR J"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0285","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2174\/1871527314666150529144655","article-title":"Glutamate transporter GLT-1 as a therapeutic target for substance use disorders","volume":"14","author":"Roberts-Wolfe","year":"2015","journal-title":"CNS Neurol Disorders-Drug Targets"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0290","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/sj.npp.1301564","article-title":"Drug addiction as a pathology of staged neuroplasticity","volume":"33","author":"Kalivas","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0295","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00726-015-2117-8","article-title":"Clavulanic acid enhances glutamate transporter subtype I (GLT-1) expression and decreases reinforcing efficacy of cocaine in mice","volume":"48","author":"Kim","year":"2016","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0300","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biopsych.2009.07.018","article-title":"Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking","volume":"67","author":"Knackstedt","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0305","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1124\/jpet.121.000532","article-title":"MC-100093, a novel \u03b2-lactam glutamate transporter-1 enhancer devoid of antimicrobial properties, attenuates cocaine relapse in rats","volume":"378","author":"Knackstedt","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0310","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fnbeh.2019.00262","article-title":"Understanding addiction using animal models","volume":"13","author":"Kuhn","year":"2019","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0315","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.euroneuro.2015.12.022","article-title":"Ceftriaxone attenuates cocaine relapse after abstinence through modulation of nucleus accumbens AMPA subunit expression","volume":"26","author":"LaCrosse","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0320","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/add.14793","article-title":"Dropout rates of in-person psychosocial substance use disorder treatments: a systematic review and meta-analysis","volume":"115","author":"Lappan","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0325","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/npp.2012.198","article-title":"Striatal adenosine signaling regulates EAAT2 and astrocytic AQP4 expression and alcohol drinking in mice","volume":"38","author":"Lee","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0330","article-title":"Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes","volume":"283","author":"Lee","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0335","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1258\/la.2011.011087","article-title":"A step-by-step guide to systematically identify all relevant animal studies","volume":"46","author":"Leenaars","year":"2012","journal-title":"Lab Anim"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0340","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.2009.06347.x","article-title":"Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro","volume":"111","author":"Lewerenz","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0345","doi-asserted-by":"crossref","DOI":"10.1186\/s12868-021-00659-8","article-title":"Ceftriaxone therapy attenuates brain trauma in rats by affecting glutamate transporters and neuroinflammation and not by its antibacterial effects","volume":"22","author":"Lim","year":"2021","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0350","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s00213-020-05514-y","article-title":"Ceftriaxone and mGlu2\/3 interactions in the nucleus accumbens core affect the reinstatement of cocaine-seeking in male and female rats","volume":"237","author":"Logan","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0355","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0360","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1007\/s00213-015-3913-2","article-title":"Effect of ceftriaxone and topiramate treatments on naltrexone-precipitated morphine withdrawal and glutamate receptor desensitization in the rat locus coeruleus","volume":"232","author":"Medrano","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0365","doi-asserted-by":"crossref","DOI":"10.1111\/1469-0691.12494","article-title":"The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses","volume":"20","author":"Melsen","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0370","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.3390\/biom5043112","article-title":"Overview of glutamatergic dysregulation in central pathologies","volume":"5","author":"Miladinovic","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2008.02.004","article-title":"Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington\u2019s disease phenotype in the R6\/2 mouse","volume":"153","author":"Miller","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2006.04.037","article-title":"Antidepressant-Like Effects of Ceftriaxone in Male C57BL\/6J Mice","volume":"61","author":"Mineur","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.111945","article-title":"Changes in the glutamate biomarker expression in rats vulnerable or resistant to the rewarding effects of cocaine and their reversal by ceftriaxone","volume":"370","author":"Niedzielska-Andres","year":"2019","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.neuroscience.2023.11.014_b0390","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/B978-0-12-398335-0.00016-9","article-title":"Overview of animal models of drug addiction: commonalities to human addiction","volume":"2","author":"Overstreet","year":"2013","journal-title":"Biol Res Addict: Comprehens Addict Behav Disorders"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0395","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1007\/s00213-022-06270-x","article-title":"Individual differences in cocaine seeking during voluntary abstinence predicts cocaine relapse and the circuitry mediating relapse","volume":"239","author":"Padovan-Hernandez","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0405","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/FBP.0000000000000314","article-title":"Effects of ceftriaxone on conditioned nicotine reward in rats","volume":"28","author":"Philogene-Khalid","year":"2017","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109306","article-title":"The GLT-1 enhancer clavulanic acid suppresses cocaine place preference behavior and reduces GCPII activity and protein levels in the rat nucleus accumbens","volume":"232","author":"Philogene-Khalid","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0415","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/0269881113482529","article-title":"Ceftriaxone, a beta-lactam antibiotic, attenuates relapse-like ethanol-drinking behavior in alcohol-preferring rats","volume":"27","author":"Qrunfleh","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0420","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neuroscience.2015.03.038","article-title":"Effects of ampicillin, cefazolin and cefoperazone treatments on GLT-1 expressions in the mesocorticolimbic system and ethanol intake in alcohol-preferring rats","volume":"295","author":"Rao","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0425","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12031-014-0251-5","article-title":"Effects of ceftriaxone on chronic ethanol consumption: a potential role for xCT and GLT1 modulation of glutamate levels in male P rats","volume":"54","author":"Rao","year":"2014","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0430","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s00213-015-3868-3","article-title":"Effects of ceftriaxone on GLT1 isoforms, xCT and associated signaling pathways in P rats exposed to ethanol","volume":"232","author":"Rao","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0435","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.drugalcdep.2011.03.022","article-title":"Glutamate transporter subtype 1 (GLT-1) activator ceftriaxone attenuates amphetamine-induced hyperactivity and behavioral sensitization in rats","volume":"118","author":"Rasmussen","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0440","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/FBP.0b013e328337be10","article-title":"\u03b2-lactam antibiotic inhibits development of morphine physical dependence in rats","volume":"21","author":"Rawls","year":"2010","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0445","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.neuropharm.2008.06.052","article-title":"Beta-lactam antibiotic prevents tolerance to the hypothermic effect of a kappa opioid receptor agonist","volume":"55","author":"Rawls","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0450","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/sj.bjp.0707309","article-title":"The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats","volume":"151","author":"Rawls","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0455","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.drugalcdep.2009.10.010","article-title":"Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation","volume":"107","author":"Rawls","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-022-01967-1","article-title":"The antidepressant and anxiolytic effects of cannabinoids in chronic unpredictable stress: a preclinical systematic review and meta-analysis","volume":"12","author":"Reuveni","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2020.104872","article-title":"Glutamate transporter-1 link astrocytes with heightened aggressive behavior induced by steroid abuse in male CF1 mice","volume":"127","author":"Rodolphi","year":"2021","journal-title":"Horm Behav"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113407","article-title":"Psychological factors associated with substance use initiation during the COVID-19 pandemic","volume":"293","author":"Rogers","year":"2020","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0475","unstructured":"Rohatgi, A., 2014. WebPlotDigitizer user manual version 3.4, pp. 1\u201318. http:\/\/arohatgi.info\/WebPlotDigitizer\/app."},{"key":"10.1016\/j.neuroscience.2023.11.014_b0480","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM199205283262204","article-title":"Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis","volume":"326","author":"Rothstein","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0485","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","article-title":"\u03b2-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0490","doi-asserted-by":"crossref","first-page":"e2323","DOI":"10.1002\/brb3.2323","article-title":"The role of hippocampal glial glutamate transporter (GLT-1) in morphine-induced behavioral responses","volume":"11","author":"Saeedi","year":"2021","journal-title":"Brain Behav"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0495","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1369-1600.2006.00012.x","article-title":"Behavioural assessment of drug reinforcement and addictive features in rodents: an overview","volume":"11","author":"Sanchis-Segura","year":"2006","journal-title":"Addict Biol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0500","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuroscience.2013.03.016","article-title":"Effects of ceftriaxone on the acquisition and maintenance of ethanol drinking in peri-adolescent and adult female alcohol-preferring (P) rats","volume":"241","author":"Sari","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0505","doi-asserted-by":"crossref","DOI":"10.1186\/1423-0127-17-62","article-title":"Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6\/2 model of Huntington\u2019s disease","volume":"17","author":"Sari","year":"2010","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0510","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/alcalc\/agr023","article-title":"Ceftriaxone, a beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring rats","volume":"46","author":"Sari","year":"2011","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0515","doi-asserted-by":"crossref","first-page":"9239","DOI":"10.1523\/JNEUROSCI.1746-09.2009","article-title":"Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats","volume":"29","author":"Sari","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0520","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s12031-013-0064-y","article-title":"Ceftriaxone treatment affects the levels of GLT1 and ENT1 as well as ethanol intake in alcohol-preferring rats","volume":"51","author":"Sari","year":"2013","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0525","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuroscience.2016.04.004","article-title":"Effects of ceftriaxone on ethanol, nicotine or sucrose intake by alcohol-preferring (P) rats and its association with GLT-1 expression","volume":"326","author":"Sari","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0530","doi-asserted-by":"crossref","DOI":"10.3390\/bs12080287","article-title":"Effects of ceftriaxone on oxidative stress and inflammation in a rat model of chronic cerebral hypoperfusion","volume":"12","author":"Sattayakhom","year":"2022","journal-title":"Behav Sci"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0535","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/WNR.0b013e32834d87eb","article-title":"Glutamate transporter (GLT-1) activation enhances nicotine antinociception and attenuates nicotine analgesic tolerance","volume":"22","author":"Schroeder","year":"2011","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0540","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drugalcdep.2014.05.012","article-title":"Clavulanic acid reduces rewarding, hyperthermic and locomotor-sensitizing effects of morphine in rats: a new indication for an old drug?","volume":"142","author":"Schroeder","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-018-0265-9","article-title":"A novel rat model of comorbid PTSD and addiction reveals intersections between stress susceptibility and enhanced cocaine seeking with a role for mGlu5 receptors","volume":"8","author":"Schwendt","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0550","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1124\/pr.116.012484","article-title":"The nucleus accumbens: mechanisms of addiction across drug classes reflect the importance of glutamate homeostasis","volume":"68","author":"Scofield","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0555","first-page":"1","article-title":"The temporal relationship between antibiotic and opioid prescription on the risk of developing an opioid use disorder: A national database study","author":"Shafeek","year":"2022","journal-title":"J Addict Dis"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0560","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1523\/JNEUROSCI.4564-13.2014","article-title":"Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse","volume":"34","author":"Shen","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0565","first-page":"81","article-title":"Recent advances in animal models of drug addiction and alcoholism","volume":"13","author":"Shippenberg","year":"2002","journal-title":"Neuropsychopharmacol: Fifth Generat Progress"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0570","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14728214.2015.985203","article-title":"Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy","volume":"20","author":"Shorter","year":"2015","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0575","first-page":"115","article-title":"Molecular changes evoked by the beta-lactam antibiotic ceftriaxone across rodent models of substance use disorder and neurological disease","author":"Smaga","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107733","article-title":"Nonhuman animal models of substance use disorders: Translational value and utility to basic science","volume":"206","author":"Smith","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0585","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157488911795933893","article-title":"Promising medications for cocaine dependence treatment","volume":"6","author":"Somaini","year":"2011","journal-title":"Recent Patents on CNS Drug Discovery (Discontinued)"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0590","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbr.2011.07.041","article-title":"Ceftriaxone prevents the induction of cocaine sensitization and produces enduring attenuation of cue-and cocaine-primed reinstatement of cocaine-seeking","volume":"225","author":"Sondheimer","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0595","doi-asserted-by":"crossref","first-page":"247","DOI":"10.31887\/DCNS.2017.19.3\/rspanagel","article-title":"Animal models of addiction","volume":"19","author":"Spanagel","year":"2017","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0600","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2022.869511","article-title":"Ten points to improve reproducibility and translation of animal research","volume":"16","author":"Spanagel","year":"2022","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0605","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pbb.2017.07.001","article-title":"Ceftriaxone reduces alcohol intake in outbred rats while upregulating xCT in the nucleus accumbens core","volume":"159","author":"Stennett","year":"2017","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0610","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0091-3057(93)90364-Y","article-title":"Analgesic effects of antibiotics in rats","volume":"46","author":"Suaudeau","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0615","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neulet.2013.09.072","article-title":"Ceftriaxone attenuates locomotor activity induced by acute and repeated cocaine exposure in mice","volume":"556","author":"Tallarida","year":"2013","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0620","doi-asserted-by":"crossref","first-page":"12406","DOI":"10.1523\/JNEUROSCI.1976-12.2012","article-title":"Ceftriaxone normalizes nucleus accumbens synaptic transmission, glutamate transport, and export following cocaine self-administration and extinction training","volume":"32","author":"Trantham-Davidson","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0625","unstructured":"United Nations Office On Drugs & Crime, 2021. World Drug Report 2021. CrimRxiv."},{"key":"10.1016\/j.neuroscience.2023.11.014_b0630","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneumeth.2013.09.010","article-title":"Meta-analysis of data from animal studies: a practical guide","volume":"221","author":"Vesterinen","year":"2014","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0635","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13254","article-title":"Effects of substance use disorder on oxidative and antioxidative stress markers: A systematic review and meta-analysis","volume":"28","author":"Viola","year":"2023","journal-title":"Addict Biol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108385","article-title":"Research on substance use disorders during the COVID-19 pandemic","volume":"129","author":"Volkow","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0645","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","article-title":"The neuroscience of drug reward and addiction","volume":"99","author":"Volkow","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0655","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/FBP.0b013e3283473c10","article-title":"\u03b2-lactam antibiotic decreases acquisition of and motivation to respond for cocaine, but not sweet food, in C57Bl\/6 mice","volume":"22","author":"Ward","year":"2011","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0660","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1377\/hlthaff.2016.0082","article-title":"Global burden of disease studies: implications for mental and substance use disorders","volume":"35","author":"Whiteford","year":"2016","journal-title":"Health Aff"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0665","unstructured":"Wilson, D.B., 2016. Formulas used by the practical meta-analysis effect size calculator. Practical meta-analysis."},{"key":"10.1016\/j.neuroscience.2023.11.014_b0670","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00236","article-title":"Repurposing of the \u03b2-lactam antibiotic, ceftriaxone for neurological disorders: A review","volume":"13","author":"Yimer","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0675","first-page":"11","article-title":"New trends of substance abuse during COVID-19 pandemic: An international perspective","author":"Zaami","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.neuroscience.2023.11.014_b0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2015.04.005","article-title":"Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer\u2019s disease","volume":"36","author":"Zumkehr","year":"2015","journal-title":"Neurobiol Aging"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452223005092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452223005092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:21:28Z","timestamp":1759681288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452223005092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":136,"alternative-id":["S0306452223005092"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2023.11.014","relation":{},"ISSN":["0306-4522"],"issn-type":[{"type":"print","value":"0306-4522"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Beta Lactams on Behavioral Outcomes of Substance Use Disorders: A Meta-Analysis of Preclinical Studies","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2023.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}